Quality of Life After Contralateral Prophylactic Mastectomy in Newly Diagnosed High-Risk Breast Cancer Patients Who Underwent <i>BRCA1</i>/<i>2</i> Gene Testing
Kenneth P. Tercyak(Georgetown University), Marc D. Schwartz(Guardia Civil), Barbara M. Brogan(Georgetown University), Tiffani A. DeMarco(Georgetown University), Claudine Isaacs(Georgetown University), Colette Magnant, Shawna C. Willey(Georgetown University), Beth N. Peshkin(Georgetown University), Sarah Rogers(Georgetown University), Marie Pennanen(Unknown)
Cited by 78
Related Papers
Elastography of breast lesions: initial clinical results.
|Radiology|1997|934
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study Group
|Journal of Clinical Oncology|2005|406